RSS
TwitterFacebook

Tag Archives: Nephrogenic Systemic Fibrosis

NSF Cases Disappeared Following MRI Contrast Guidelines: Study

Restrictive guidelines put in place on gadolinium-based contrast agents (GBCAs) used during some MRI examinations appear to be working, according to the findings of U.S. researchers, who report that they have not identified any new cases of nephrogenic systemic fibrosis (NSF) among individuals who received an enhanced MRI with contrast after the guidelines were adopted. …

GE Healthcare Omniscan Lawsuit Settled on Eve of Trial

The first trial over nephrogenic systemic fibrosis (NSF) from Omniscan, a gadolinium-based MRI contrast agent manufactured by GE Healthcare, was settled in a last minute deal reached the night before trial was set to begin in federal court in Cleveland on Monday.…

FDA Warns Not to Use Some MRI Contrast Agents With Kidney Patients

The FDA is banning the use of three major brands of MRI contrast agent on patients with kidney problems, and is forcing other manufacturers to change their labels to bring more attention to the risk of nephrogenic systemic fibrosis (NSF), a potentially fatal side effects of the gadolinium-based contrasting agents. …